Ivim Health Review

Ivim Health: a low entry price with a fee structure worth reading twice

Ivim Health is built for one kind of shopper above all others: the person scanning telehealth weight-loss programs for the lowest possible starting number on compounded semaglutide. At $75 a month for the entry tier, it lands near the bottom of the field and well under the category median of $170. That headline figure is real, and it is the main reason to look here. But Ivim's pricing has a second layer that the sticker number doesn't show, and whether this provider is actually a bargain depends entirely on which medication you end up on. This review walks through how the money really works, what you get, and who should keep scrolling to a simpler option.

How the pricing actually works

The $75 monthly rate covers compounded semaglutide, and for that drug Ivim is genuinely cheap. Where it gets more complicated is tirzepatide. Ivim prices the tirzepatide medication at a low three-figure monthly rate, but it layers a separate monthly program fee on top of it — roughly a high-double-digit charge that funds the membership side of the service. So the tirzepatide path is really two line items added together, and the combined monthly cost is meaningfully higher than the semaglutide entry tier suggests. Ivim doesn't run a discounted first-month teaser rate, so there's no promo number to chase and no price jump to brace for after month one — what you sign up for is what you keep paying.

• Semaglutide: the advertised $75/mo entry tier, the cleanest deal here.
• Tirzepatide: a low three-figure medication rate plus a separate monthly program fee — budget for both.
• No teaser pricing: the rate you start on is the rate that continues, which makes month-to-month planning easier.

The practical takeaway: if you read '$75 a month' and assumed it applied to whatever GLP-1 you wanted, that's the trap to avoid. Price out the specific drug you're after, fee included, before you compare Ivim to anyone else.

The medications and how you get them

Ivim's core offerings are compounded semaglutide and compounded tirzepatide — the same active ingredients as Wegovy, Ozempic, Zepbound and Mounjaro, made by a compounding pharmacy rather than the brand manufacturer. Notably, Ivim also confirms access to brand-name options including Zepbound, Mounjaro, Ozempic, Wegovy, Saxenda and liraglutide, which is a wider menu than many budget-tier programs carry. Most people come for the low-cost compounded route, but having the brand-name path available means you aren't boxed in if your prescriber recommends an FDA-approved product or your situation changes.

What the membership actually buys you

That separate program fee isn't only an upcharge — it's tied to a membership that includes unlimited provider visits and access to functional health coaches. In plain terms, you can message and meet with the clinical team as often as you need without per-visit charges, and there's a coaching layer aimed at the lifestyle side of weight loss rather than just shipping you a vial. Ivim's plan bundles the medication, the medical consult and coaching together, so for someone who wants ongoing contact rather than a transactional refill, the fee buys real support. For someone who just wants the cheapest possible monthly injection and no hand-holding, that same fee is mostly dead weight.

Who this is genuinely for

• Budget-focused patients who specifically want compounded semaglutide at one of the lowest monthly rates available.
• People who value unlimited provider access and coaching, and will actually use it enough to justify the program fee.
• Shoppers who want the option to move to a brand-name GLP-1 later without switching providers.

Who should skip it

• Anyone set on tirzepatide purely for a rock-bottom price — once the program fee is added, the math is no longer a standout, and dedicated low-cost tirzepatide programs may beat it.
• Self-directed patients who won't use coaching or frequent visits and resent paying a membership fee for them.
• People who need to confirm their state is served before committing — Ivim doesn't publish its coverage map (more on that below).

Trust, oversight and the gaps to know about

On the safety side, the encouraging news is that there are no FDA warning letters on file for Ivim in our records, and the program is structured as real clinical care — medical consult, prescriber visits and coaching included — not a no-questions pill mill. The honest caveat is transparency. Ivim doesn't publicly disclose which states it serves; you generally have to start the intake or contact the company to confirm you're eligible, which is friction other providers spare you. We also don't have a named, accreditation-verified compounding pharmacy on record for Ivim, so while the medications are confirmed available, the specific sourcing chain is less documented than at providers that name an accredited 503A or 503B partner outright. That puts our verification confidence in the moderate range: the prices and product menu are live-verified, but the operational details behind them are thinner than ideal. Our scoring methodology treats that kind of disclosure gap as a real, if not disqualifying, mark against a provider.

Bottom line

Ivim Health is a legitimately strong pick if — and it's a real if — you want compounded semaglutide at a near-bottom price and you'll use the unlimited visits and coaching that the membership provides. At $75 a month for the entry tier, well below the $170 median, the semaglutide deal is hard to argue with. The asterisk is tirzepatide: the separate program fee changes the calculus, so price out your exact drug, fee included, before you decide. And go in expecting to confirm your state eligibility directly, since Ivim keeps that information behind the signup door. Cheap on the surface, slightly more nuanced underneath — worth it for the right semaglutide shopper, less obviously so for everyone else.

If you're weighing alternatives, Telos Rx ($49/month) and bmiMD ($99/month) are among the closest options we track to Ivim Health.